⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9617803 | 0.73 | — | — | |
| SCHEMBL19886830 | 0.67 | — | — | |
| SCHEMBL12186237 | 0.65 | — | — | |
| SCHEMBL9044064 | 0.65 | — | — | |
| SCHEMBL13162792 | 0.65 | — | — | |
| SCHEMBL13663709 | 0.62 | — | — | |
| SCHEMBL15941919 | 0.57 | — | — | |
| SCHEMBL14154737 | 0.57 | — | — | |
| SCHEMBL19144690 | 0.56 | — | — | |
| SCHEMBL3346347 | 0.55 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-104045642-A | Fused ring compound containing pyrimidine or pyridine and its application as antitumor drug | CISEN PHARMACEUTICAL CO LTD | 2014-09-17 | — | — | CN | disclosed |
| CN-100506823-C | Pyridopyrimidines and pyrimidopyrimidine derivatives as antiproliferative agents | JANSSEN PHARMACEUTICA NV (BE) | 2009-07-01 | — | — | CN | disclosed |
| CN-1894260-A | Pyridopyrimidines and pyrimidopyrimidine derivatives as antiproliferative agents | JANSSEN PHARMACEUTICA NV (BE) | 2007-01-10 | — | — | CN | disclosed |
| CN-1493291-A | Dicyclic compound capable of inhibiting epidermis growth factor acceptor rotatory tyrosine kinase | ��ʲ | 2004-05-05 | — | — | CN | disclosed |
| CN-1140269-C | Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family | ��ʲ | 2004-03-03 | — | — | CN | disclosed |
| CN-1139383-A | Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family | WARNER LAMBERT CO (US) | 1997-01-01 | — | — | CN | disclosed |
| WO-1995019774-A1 | BICYCLIC COMPOUNDS CAPABLE OF INHIBITING TYROSINE KINASES OF THE EPIDERMAL GROWTH FACTOR RECEPTOR FAMILY | WARNER-LAMBERT COMPANY (US) | 1995-07-27 | — | — | WO | disclosed |